Evidence map›Paper›PMID 40115679›Full record

ArticleCureus2025

Herpes Simplex Virus (HSV) Pneumonitis as a Late Complication of COVID-19 Infection: A Unique Case Report.

Shirisha Pasula, Rupalakshmi Vijayan

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Shirisha PasulaInternal Medicine/Infectious Diseases, University of California, Fresno, USA.
Rupalakshmi VijayanFamily Medicine, St. Elizabeth Mercy Boardman Hospital, Boardman, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This case report details a patient who presented with gradually worsening shortness of breath and hemoptysis over a year following her COVID-19 infection. Notably, the patient was otherwise immunocompetent. After a comprehensive evaluation, she was diagnosed with herpes simplex virus (HSV) pneumonitis. The patient was treated with oral acyclovir, which is the standard approach for managing HSV pneumonitis. This case highlights the potential for delayed HSV reactivation and the need for awareness of such complications in patients recovering from COVID-19.

Indexed as

hemoptysishsv pneumonitisimmunocompetent adultspost-covid-19 complicationspulmonary infiltrates

Identifiers

PMID40115679
PMCPMC11925227

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.